Resources from the same session
LBA36 - Efficacy and safety of senaparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer (FLAMES study): A randomized, double-blind, placebo-controlled, phase III trial
Presenter: Xiaohua Wu
Session: Proffered Paper session 1 - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
LBA37 - Atezolizumab (atezo) combined with platinum-based chemotherapy (CT) and maintenance niraparib for recurrent ovarian cancer (rOC) with a platinum-free interval (TFIp) >6 months: Primary analysis of the double-blind placebo (pbo)-controlled ENGOT-Ov41/GEICO 69-O/ANITA phase III trial
Presenter: Antonio Gonzalez Martin
Session: Proffered Paper session 1 - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA36 and LBA37
Presenter: Charlie Gourley
Session: Proffered Paper session 1 - Gynaecological cancers
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Gynaecological cancers
Resources:
Slides
Webcast
LBA38 - Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study
Presenter: Domenica Lorusso
Session: Proffered Paper session 1 - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Gynaecological cancers
Resources:
Slides
Webcast